Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

MESA
Mesa Labs reports 4Q26 revenues +2.6%, operating income surges 87% to $2,748K

Mesa Laboratories posted fourth quarter fiscal 2026 results with 2.6% revenue growth and 87% operating income increase, while reducing debt by $14.7M....

MONRO,
Monro Q4 gross margin expands 90bps YoY despite 7.2% sales decline

Monro reported Q4 fiscal 2026 sales decreased 7.2% to $273.8M, primarily from 145 store closures and comparable store sales decline of 2.4%, while gro...

ABERCROMBIE
Abercrombie & Fitch reports record Q1 FY2026 sales of $1.1B, maintains full-year guidance

Abercrombie & Fitch delivered record first quarter net sales of $1.1 billion with 14 consecutive quarters of growth, driven by strong Americas and APA...

Translational
Translational Development Acquisition Corp. to merge with Prologium Holding Inc.

TDAC, a blank check company, has entered into a merger agreement with Prologium Holding Inc. dated May 27, 2026, involving two sequential mergers that...

Zeo
ZEO ScientifiX launches physician-led patient education program in Southeast

ZEO ScientifiX formalized a Physician-Led Patient Masterclass program following grassroots demand, building on its network of 600+ trained physicians ...

PRECISION
PBGENE-HBV shows first clinical evidence of cccDNA elimination in hepatitis B patients

Precision BioSciences announced late-breaking clinical data from the ELIMINATE-B study demonstrating that PBGENE-HBV directly eliminated cccDNA with a...

MOVADO
Movado Group Q1 FY2027 earnings beat expectations with 8% sales growth

Movado reported Q1 FY2027 net sales of $142.4M (+8% YoY) with diluted EPS of $0.30 versus $0.06 prior year, while expanding gross margins 320 basis po...

G
G-III Apparel Group declares quarterly dividend of $0.10 per share

G-III Apparel Group's Board of Directors declared a quarterly cash dividend of $0.10 per share, payable July 8, 2026 to stockholders of record on June...

Bath
Bath & Body Works Q1 2026 earnings beat guidance despite 3% sales decline

Bath & Body Works reported first quarter net sales of $1.4 billion, down 3% year-over-year, but exceeded earnings guidance with adjusted EPS of $0.32....

Tonix
Tonix Pharmaceuticals publishes Phase 1 data for TNX-1500 anti-CD40L antibody

Tonix announced publication of Phase 1 clinical data for TNX-1500 in the Journal of Clinical Immunology, showing the drug was well-tolerated with favo...

Sound
Sound Point Meridian reports Q4 2026 net loss of $74.7M amid portfolio decline

The closed-end investment company reported a GAAP net loss of $74.7 million ($3.63 per share) for Q4 ended March 31, 2026, driven by $77.6 million in ...

NorthWestern
NorthWestern Energy presents merger transaction details with Black Hills at Bank of America conference

NorthWestern Energy Group disclosed forward-looking statements regarding its proposed merger with Black Hills Corporation at the Bank of America Power...

DYCOM
Dycom Industries reports record Q1 FY2027 results, raises full-year guidance

Dycom delivered record first quarter results with $1.965B in contract revenues, up 56.1%, and adjusted EPS of $4.42, exceeding guidance while announci...

DICK'S
Dick's Sporting Goods Q1 profit beats with 6% comp growth; raises 2026 guidance

Dick's Sporting Goods reported Q1 earnings of $3.54 per share with 6% comparable sales growth in its core business, while the Foot Locker acquisition ...

IMMUNIC,
IMMUNIC appoints Erik Lundgren as Chief Executive Officer

IMMUNIC, INC. has entered into an employment agreement with Erik Lundgren to serve as CEO effective May 22, 2026. The appointment represents a leaders...

Capri
Capri Holdings returns to profitability; FY2027 guidance targets low-single-digit revenue growth, 40% EPS growth

Capri Holdings reported Q4 FY2026 results showing return to profitability with strategic initiatives for Michael Kors and Jimmy Choo gaining traction....

Apogee
Apogee Therapeutics secures $1.3B non-dilutive financing from Blackstone Life Sciences

Apogee Therapeutics announced a strategic financing collaboration with Blackstone Life Sciences providing up to $1.3 billion in non-dilutive capital, ...

Apogee
Apogee Therapeutics reports positive Phase 2 APEX trial results for zumilokibart in atopic dermatitis

Apogee announced positive 16-week Part B induction dose optimization results from its Phase 2 APEX trial of zumilokibart, with 65.9% of mid-dose patie...

Nano
Nano Dimension sells MarkForged to Stratasys for $42.5M in cash

Nano Dimension agreed to sell its MarkForged subsidiary to Stratasys for $42.5 million in an all-cash transaction expected to close in H2 2026. The sa...

Streamex
Streamex appoints ex-Microsoft and PayPal designer Kori Handy as VP of Product

Streamex Corp. announced the appointment of Kori Handy as Vice President of Product and Design, bringing 18 years of fintech and SaaS experience from ...